These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36307634)

  • 1. Diagnostic role of DOG-1, GFAP and B-catenin in Basal cell Adenoma and Cellular Pleomorphic Adenoma of the Salivary Gland.
    López-Janeiro Á; Blasco-Santana L; Pérez-Pérez M; Ruiz-Bravo E
    Head Neck Pathol; 2023 Jun; 17(2):339-346. PubMed ID: 36307634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive pattern of glial fibrillary acidic protein immunoreactivity useful in distinguishing fragmented pleomorphic adenoma, canalicular adenoma and polymorphous low grade adenocarcinoma of minor salivary glands.
    Curran AE; Allen CM; Beck FM; Damm DD; Murrah VA
    Head Neck Pathol; 2007 Sep; 1(1):27-32. PubMed ID: 20614277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
    Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEF-1: Diagnostic utility in distinguishing basaloid neoplasms of the salivary gland.
    Schmitt AC; Griffith CC; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2017 Dec; 45(12):1078-1083. PubMed ID: 28972308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial Fibrillary Acidic Protein Expression Helps Distinguish Pleomorphic Adenoma from Histologic Mimics.
    Gorski Z; Purgina B; Wasserman JK
    Head Neck Pathol; 2022 Sep; 16(3):695-702. PubMed ID: 35064902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein and CD57 immunolocalization in cell block preparations is a useful adjunct in the diagnosis of pleomorphic adenoma.
    Shah SS; Chandan VS; Wilbur DC; Khurana KK
    Arch Pathol Lab Med; 2007 Sep; 131(9):1373-7. PubMed ID: 17824792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.
    Avadhani V; Cohen C; Siddiqui MT
    Acta Cytol; 2016; 60(3):240-5. PubMed ID: 27463119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of pleomorphic adenoma by immunohistochemical means.
    Nishimura T; Furukawa M; Kawahara E; Miwa A
    J Laryngol Otol; 1991 Dec; 105(12):1057-60. PubMed ID: 1664847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of vimentin, cytokeratin and S-100 in monomorphic adenoma of salivary gland; value of marker studies in the differential diagnosis of salivary gland tumours.
    Gupta RK; Naran S; Dowle C; Simpson JS
    Cytopathology; 1992; 3(5):303-9. PubMed ID: 1283826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphous low-grade adenocarcinoma versus pleomorphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acidic protein.
    Curran AE; White DK; Damm DD; Murrah VA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Feb; 91(2):194-9. PubMed ID: 11174597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.
    Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR
    Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial fibrillary acid protein immunoreactivity in fine-needle aspiration of salivary gland lesions: a useful adjunct for the differential diagnosis of salivary gland neoplasms.
    Ostrzega N; Cheng L; Layfield L
    Diagn Cytopathol; 1989; 5(2):145-9. PubMed ID: 2550189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cell adenoma and pleomorphic adenoma of the parotid gland: a single center experience.
    Bianchini C; Brugali M; Migliorelli A; Corazzi V; Cammaroto G; Meccariello G; Stomeo F; Ciorba A; Pelucchi S
    Minerva Surg; 2023 Dec; 78(6):626-632. PubMed ID: 37530711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study.
    do Prado RF; Consolaro A; Taveira LA
    Med Oral Patol Oral Cir Bucal; 2006 May; 11(3):E247-51. PubMed ID: 16648762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
    Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
    Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
    Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
    Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the diagnostic accuracy for pleomorphic adenoma and Warthin tumor by employing the Milan System for Reporting Salivary Gland Cytopathology: An international, multi-institutional study.
    Allison DB; Smith AP; An D; Miller JA; Shafique K; Song S; Viswanathan K; Eykman E; Rao RA; Wiles A; Barkan GA; Nayar R; Fadda G; Powers CN; Rossi ED; Siddiqui MT; Ali SZ; Kholová I; Layfield LJ; Field A; Baloch Z; Maleki Z
    Cancer Cytopathol; 2021 Jan; 129(1):43-52. PubMed ID: 32767837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical study of pleomorphic adenomas of the salivary gland: glial fibrillary acidic protein-like immunoreactivity identifies a major myoepithelial component.
    Stead RH; Qizilbash AH; Kontozoglou T; Daya AD; Riddell RH
    Hum Pathol; 1988 Jan; 19(1):32-40. PubMed ID: 2447009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Don't SUMP it! Utility of PLAG1 immunocytochemistry in basaloid SUMP subcategory.
    Sanchez-Avila M; Tjendra Y; Zuo Y; Ruiz-Cordero R; Garcia-Buitrago M; Jorda M; Gomez-Fernandez C; Velez Torres JM
    Cancer Cytopathol; 2024 Jan; 132(1):60-68. PubMed ID: 37702124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial fibrillary acidic protein in tumor types with cartilaginous differentiation.
    Santos GC; Carvalho KC; Falzoni R; Simoes AC; Rocha RM; Lopes A; Vassallo J; Reis LF; Soares FA; da Cunha IW
    Mod Pathol; 2009 Oct; 22(10):1321-7. PubMed ID: 19668151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.